MJRX — Global Health Clinics Income Statement
0.000.00%
Last trade - 00:00
- CA$0.23m
- CA$1.42m
- CA$0.10m
2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.488 | 0.352 | 0.225 | 0.147 | 0.103 |
Cost of Revenue | |||||
Gross Profit | 0.153 | 0.187 | 0.178 | 0.116 | 0.081 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 17.2 | 2.06 | 8.6 | 1.62 | 1.73 |
Operating Profit | -16.7 | -1.7 | -8.38 | -1.47 | -1.63 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -16.7 | -1.7 | -8.48 | -1.37 | -1.63 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.3 | -1.7 | -8.48 | -1.37 | -1.63 |
Net Income Before Extraordinary Items | |||||
Net Income | -16.3 | -1.7 | -8.48 | -1.37 | -1.63 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16.3 | -1.7 | -8.48 | -1.37 | -1.63 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -31.1 | -4.6 | -0.684 | -0.365 | -0.173 |
Dividends per Share |